Jonathan Pearson-Stuttard1, Maria Guzman-Castillo2, Jose L Penalvo2, Colin D Rehm2, Ashkan Afshin2, Goodarz Danaei2, Chris Kypridemos2, Tom Gaziano2, Dariush Mozaffarian2, Simon Capewell2, Martin O'Flaherty2. 1. From Department of Public Health and Policy, University of Liverpool, UK(J.P.-S., M.G.-C., C.K., S.C.., M.O.); Department of Primary Care and Public Health, Imperial College London, UK (J.P.-S); Friedman School of Nutrition Science and Policy, Tufts University, Boston, MA(J.L.P., C.D.R., A.A., D.M.); Harvard T.H. Chan School of Public Health, Boston, MA(G.D.); and Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA(T.G.). j.pearson-stuttard@imperial.ac.uk. 2. From Department of Public Health and Policy, University of Liverpool, UK(J.P.-S., M.G.-C., C.K., S.C.., M.O.); Department of Primary Care and Public Health, Imperial College London, UK (J.P.-S); Friedman School of Nutrition Science and Policy, Tufts University, Boston, MA(J.L.P., C.D.R., A.A., D.M.); Harvard T.H. Chan School of Public Health, Boston, MA(G.D.); and Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA(T.G.).
Abstract
BACKGROUND: Accurate forecasting of cardiovascular disease mortality is crucial to guide policy and programming efforts. Prior forecasts often have not incorporated past trends in rates of reduction in cardiovascular disease mortality. This creates uncertainties about future trends in cardiovascular disease mortality and disparities. METHODS AND RESULTS: To forecast US cardiovascular disease mortality and disparities to 2030, we developed a hierarchical bayesian model to determine and incorporate prior age, period, and cohort effects from 1979 to 2012, stratified by age, sex, and race, which we combined with expected demographic shifts to 2030. Data sources included the National Vital Statistics System, Surveillance, Epidemiology, and End Results (SEER) single-year population estimates, and US Bureau of Statistics 2012 national population projections. We projected coronary disease and stroke deaths to 2030, first on the basis of constant age, period, and cohort effects at 2012 values, as is most commonly done (conventional), and then with the use of more rigorous projections incorporating expected trends in age, period, and cohort effects (trend based). We primarily evaluated absolute mortality. The conventional model projected total coronary and stroke deaths by 2030 to increase by ≈18% (67 000 additional coronary deaths per year) and 50% (64 000 additional stroke deaths per year). Conversely, the trend-based model projected that coronary mortality would decrease by 2030 by ≈27% (79 000 fewer deaths per year) and stroke mortality would remain unchanged (200 fewer deaths per year). Health disparities will be improved in stroke deaths but not coronary deaths. CONCLUSIONS: After prior mortality trends and expected demographic shifts are accounted for, total US coronary deaths are expected to decline, whereas stroke mortality will remain relatively constant. Health disparities in stroke but not coronary deaths will be improved but not eliminated. These age, period, and cohort approaches offer more plausible predictions than conventional estimates.
BACKGROUND: Accurate forecasting of cardiovascular disease mortality is crucial to guide policy and programming efforts. Prior forecasts often have not incorporated past trends in rates of reduction in cardiovascular disease mortality. This creates uncertainties about future trends in cardiovascular disease mortality and disparities. METHODS AND RESULTS: To forecast US cardiovascular disease mortality and disparities to 2030, we developed a hierarchical bayesian model to determine and incorporate prior age, period, and cohort effects from 1979 to 2012, stratified by age, sex, and race, which we combined with expected demographic shifts to 2030. Data sources included the National Vital Statistics System, Surveillance, Epidemiology, and End Results (SEER) single-year population estimates, and US Bureau of Statistics 2012 national population projections. We projected coronary disease and stroke deaths to 2030, first on the basis of constant age, period, and cohort effects at 2012 values, as is most commonly done (conventional), and then with the use of more rigorous projections incorporating expected trends in age, period, and cohort effects (trend based). We primarily evaluated absolute mortality. The conventional model projected total coronary and stroke deaths by 2030 to increase by ≈18% (67 000 additional coronary deaths per year) and 50% (64 000 additional stroke deaths per year). Conversely, the trend-based model projected that coronary mortality would decrease by 2030 by ≈27% (79 000 fewer deaths per year) and stroke mortality would remain unchanged (200 fewer deaths per year). Health disparities will be improved in stroke deaths but not coronary deaths. CONCLUSIONS: After prior mortality trends and expected demographic shifts are accounted for, total US coronary deaths are expected to decline, whereas stroke mortality will remain relatively constant. Health disparities in stroke but not coronary deaths will be improved but not eliminated. These age, period, and cohort approaches offer more plausible predictions than conventional estimates.
Authors: Michelle C Odden; Pamela G Coxson; Andrew Moran; James M Lightwood; Lee Goldman; Kirsten Bibbins-Domingo Journal: Am J Med Date: 2011-06-30 Impact factor: 4.965
Authors: Paul A Heidenreich; Justin G Trogdon; Olga A Khavjou; Javed Butler; Kathleen Dracup; Michael D Ezekowitz; Eric Andrew Finkelstein; Yuling Hong; S Claiborne Johnston; Amit Khera; Donald M Lloyd-Jones; Sue A Nelson; Graham Nichol; Diane Orenstein; Peter W F Wilson; Y Joseph Woo Journal: Circulation Date: 2011-01-24 Impact factor: 29.690
Authors: Goodarz Danaei; Eric B Rimm; Shefali Oza; Sandeep C Kulkarni; Christopher J L Murray; Majid Ezzati Journal: PLoS Med Date: 2010-03-23 Impact factor: 11.069
Authors: Manuel Franco; Pedro Orduñez; Benjamín Caballero; José A Tapia Granados; Mariana Lazo; José Luís Bernal; Eliseo Guallar; Richard S Cooper Journal: Am J Epidemiol Date: 2007-09-19 Impact factor: 4.897
Authors: Earl S Ford; Umed A Ajani; Janet B Croft; Julia A Critchley; Darwin R Labarthe; Thomas E Kottke; Wayne H Giles; Simon Capewell Journal: N Engl J Med Date: 2007-06-07 Impact factor: 91.245
Authors: Emelia J Benjamin; Michael J Blaha; Stephanie E Chiuve; Mary Cushman; Sandeep R Das; Rajat Deo; Sarah D de Ferranti; James Floyd; Myriam Fornage; Cathleen Gillespie; Carmen R Isasi; Monik C Jiménez; Lori Chaffin Jordan; Suzanne E Judd; Daniel Lackland; Judith H Lichtman; Lynda Lisabeth; Simin Liu; Chris T Longenecker; Rachel H Mackey; Kunihiro Matsushita; Dariush Mozaffarian; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Latha Palaniappan; Dilip K Pandey; Ravi R Thiagarajan; Mathew J Reeves; Matthew Ritchey; Carlos J Rodriguez; Gregory A Roth; Wayne D Rosamond; Comilla Sasson; Amytis Towfighi; Connie W Tsao; Melanie B Turner; Salim S Virani; Jenifer H Voeks; Joshua Z Willey; John T Wilkins; Jason Hy Wu; Heather M Alger; Sally S Wong; Paul Muntner Journal: Circulation Date: 2017-01-25 Impact factor: 29.690
Authors: Maria Lopez-Class; Emmanuel Peprah; Xinzhi Zhang; Peter G Kaufmann; Michael M Engelgau Journal: Ethn Dis Date: 2016-07-21 Impact factor: 1.847
Authors: George A Mensah; Gina S Wei; Paul D Sorlie; Lawrence J Fine; Yves Rosenberg; Peter G Kaufmann; Michael E Mussolino; Lucy L Hsu; Ebyan Addou; Michael M Engelgau; David Gordon Journal: Circ Res Date: 2017-01-20 Impact factor: 17.367
Authors: Arleen F Brown; Li-Jung Liang; Stefanie D Vassar; Jose J Escarce; Sharon Stein Merkin; Eric Cheng; Adam Richards; Teresa Seeman; W T Longstreth Journal: Ann Intern Med Date: 2018-03-20 Impact factor: 25.391
Authors: Bernhard Haring; Adam Omidpanah; Astrid M Suchy-Dicey; Lyle G Best; Steven P Verney; Dean K Shibata; Shelley A Cole; Tauqeer Ali; Barbara V Howard; Dedra Buchwald; Richard B Devereux Journal: Hypertension Date: 2017-09-11 Impact factor: 10.190
Authors: Jonathan Pearson-Stuttard; Piotr Bandosz; Colin D Rehm; Ashkan Afshin; Jose L Peñalvo; Laurie Whitsel; Goodarz Danaei; Renata Micha; Tom Gaziano; Ffion Lloyd-Williams; Simon Capewell; Dariush Mozaffarian; Martin O'Flaherty Journal: Am J Clin Nutr Date: 2017-05-31 Impact factor: 7.045
Authors: Krishna Ravindra; Marco G Del Buono; Juan G Chiabrando; Peter Westman; Edoardo Bressi; Dinesh Kadariya; Curtis Maehara; Megan Dell; Liangsuo Ma; Jessie VAN Wezenbeek; F Gerard Moeller; Lori Keyser-Marcus; Larry D Keen; Tamas S Gal; Antonio Abbate Journal: Minerva Cardiol Angiol Date: 2021-01-11